MARKET

HCM

HCM

Hutchmed (China) Limited
NASDAQ
13.45
-0.54
-3.86%
After Hours: 13.45 0 0.00% 16:10 11/19 EST
OPEN
13.97
PREV CLOSE
13.99
HIGH
14.00
LOW
13.41
VOLUME
37.53K
TURNOVER
--
52 WEEK HIGH
16.33
52 WEEK LOW
9.77
MARKET CAP
2.35B
P/E (TTM)
130.33
1D
5D
1M
3M
1Y
5Y
1D
HUTCHMED (China) Limited Announces China NMPA Approval of SYVIK® and Highlights HMPL-A830 Pre-Clinical Data
NASDAQ · 15h ago
Hutchmed announces China NMPA approval of Syvik NDAs
TipRanks · 16h ago
HUTCHMED Receives China National Medical Products Administration Simultaneous Approval For Two New Drug Applications For Syvik Oral Small Molecule Inhibitor Targeting Spleen Tyrosine Kinase
Benzinga · 16h ago
HUTCHMED's Cancer Candidate Shows Activity Across KRAS Alterations In Preclinical Tests
NASDAQ · 19h ago
Weekly Report: what happened at HCM last week (1109-1113)?
Weekly Report · 3d ago
BOCOM International Holdings Company Sticks to Their Buy Rating for HUTCHMED (China) (HCM)
TipRanks · 11/11 05:15
Weekly Report: what happened at HCM last week (1102-1106)?
Weekly Report · 11/09 09:58
Citi Remains a Buy on HUTCHMED (China) (HCM)
TipRanks · 11/07 00:25
More
About HCM
HUTCHMED (China) Ltd is an investment holding company principally engaged in the manufacture and sale of pharmaceuticals. The Company operates its business through two segments. Oncology Immunology segment is engaged in the discovery, development and commercialization of targeted therapies and immunotherapies for the treatment of cancer and immunological diseases. Among it, research and development (R&D) includes research and development activities covering drug discovery, development, manufacturing and regulatory functions, out-licensing of in-house developed drugs, as well as administrative activities to support research and development operations, marketed products comprises the invoiced sales, marketing, manufacture and distribution of drugs developed from research and development activities. Other Ventures segment is engaged in the other commercial businesses which include the sales, marketing, manufacture and distribution of other prescription drugs and healthcare products.

Webull offers HUTCHMED (China) Ltd (ADR) stock information, including NASDAQ: HCM real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, HCM stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading HCM stock methods without spending real money on the virtual paper trading platform.